Gelonghui Reports CMS’ Successful Phase III Study of Methylthioninium Chloride Enteric-coated Sustained-release Tablets
SHENZHEN, CHINA, Dec 19, 2022 – (ACN Newswire via SEAPRWire.com) – Gelonghui released a Press Release on “China Medical System Holdings Limited’s innovative product Methylthioninium Chloride Enteric-coated Sustained-release Tablets (‘the Product’) has obtained positive results for its Phase III clinical trial in China.” This is another breakthrough for the Product after China Medical System Holdings... » read more